Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1677
    +0.0021 (+0.18%)
     

  • GBP/USD

    1.2495
    -0.0016 (-0.13%)
     

  • Bitcoin GBP

    51,189.14
    -445.33 (-0.86%)
     

  • CMC Crypto 200

    1,332.20
    -64.34 (-4.61%)
     

  • S&P 500

    5,102.87
    +54.45 (+1.08%)
     

  • DOW

    38,271.41
    +185.61 (+0.49%)
     

  • CRUDE OIL

    83.89
    +0.32 (+0.38%)
     

  • GOLD FUTURES

    2,351.80
    +9.30 (+0.40%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

At least six funds interested in Sanofi European generic drugs unit -Le Figaro

Reuters - UK Focus

PARIS, Oct (Shenzhen: 000069.SZ - news) 5 (Reuters) - French pharmaceutical group Sanofi (LSE: 0O59.L - news) is set to start the process to sell its generic drug business in Europe, and at least six funds have expressed interest to investment banks mandated by group, France's Le Figaro newspaper reported.

Rothschild and JP Morgan, two investment banks mandated by Sanofi to handle the divestment, will send out memos to potential buyers in the next few weeks, Le Figaro said in its Friday edition.

Sources told Reuters in March that Rothschild, JP Morgan (Other OTC: MGHL - news) and Morgan Stanley (Xetra: 885836 - news) had been asked to organise the long-awaited deal.

Many investment funds have shown an interest including Blackstone (NYSE: BX - news) , CVC (Taiwan OTC: 4744.TWO - news) , BC Partners, Carlyle, Cinven and Advent, the paper said, without citing its sources. It added that the bankers were expecting the first indicative bids within two months.

ADVERTISEMENT

It said Sanofi was expecting about 3 billion euros ($3.51 billion) from the sale.

A spokesperson for Sanofi declined to comment. The banks and funds could not be reached for comment.

Sanofi said in January that it intends to finalise the sale of the generic drugs business by the end of 2018. The unit reported about 800 million euros in sales in 2015. ($1 = 0.8543 euros) (Reporting by Dominique Rodriquez and Bate Felix)